Sharon M. Sandberg

2.2k citations

31 papers · 1.8k indexed · 1 hit paper · h-index 19

Cardiology and Cardiovascular Medicine top 2%
Physiology top 5%
Molecular Biology
Pulmonary and Respiratory Medicine top 10%
Surgery

Co-authors: John C. Burnett Denise M. Heublein Brooks S. Edwards John W. Hallett Amir Lerman Brenda K. Huntley Margaret M. Redfield Michihisa Jougasaki
Topics: Heart Failure Treatment and Management (18 papers)Renin-Angiotensin System Studies (5 papers)Nitric Oxide and Endothelin Effects (4 papers)
Cited by: Cardiology and Cardiovascular Medicine Physiology Transplantation
Journals: New England Journal of Medicine Circulation Journal of the American College of Cardiology
Partner nations: United States Japan Italy

In The Last Decade

Sharon M. Sandberg

31 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circulating and Tissue Endothelin Immunoreactivity in Advanced Atherosclerosis

1991 788 citations Amir Lerman, Brooks S. Edwards et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Sharon M. Sandberg

Since Specialization

Citations

This map shows the geographic impact of Sharon M. Sandberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon M. Sandberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon M. Sandberg more than expected).

Fields of papers citing papers by Sharon M. Sandberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon M. Sandberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon M. Sandberg. The network helps show where Sharon M. Sandberg may publish in the future.

Co-authorship network of co-authors of Sharon M. Sandberg

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon M. Sandberg. A scholar is included among the top collaborators of Sharon M. Sandberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon M. Sandberg. Sharon M. Sandberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: Regulation and therapeutic implications 2014 ·Journal of Molecular and Cellular Cardiology ·Tomoko Ichiki,John A. Schirger,Brenda K. Huntley,Frank V. Brozovich,Joseph J. Maleszewski,Sharon M. Sandberg,S. Jeson Sangaralingham,Soon J. Park,John C. Burnett	45
2	Abstract 12951: Human C-Type Natriuretic Peptide-53: A Distinct Molecular Form With in vitro and in vivo Biological Actions Through cGMP Generation 2014 ·Circulation ·S. Jeson Sangaralingham,Brenda K. Huntley,Tomoko Ichiki,Sharon M. Sandberg,John C. Burnett	1
3	Urinary C-Type Natriuretic Peptide 2013 ·JACC Heart Failure ·Rosita Zakeri,S. Jeson Sangaralingham,Sharon M. Sandberg,Denise M. Heublein,Christopher G. Scott,John C. Burnett	29
4	Endothelial permeability in vitro and in vivo: Protective actions of ANP and omapatrilat in experimental atherosclerosis 2013 ·Peptides ·Tomoko Ichiki,(unknown),Alessandro Cataliotti,(unknown),Sharon M. Sandberg,John C. Burnett	21
5	Human Hypertension Is Characterized by a Lack of Activation of the Antihypertensive Cardiac Hormones ANP and BNP 2012 ·Journal of the American College of Cardiology ·Fima Macheret,Denise M. Heublein,Lisa C. Costello‐Boerrigter,Guido Boerrigter,Paul M. McKie,Diego Bellavia,Sarah Mangiafico,Yasuhiro Ikeda,Kent R. Bailey,Christopher G. Scott,Sharon M. Sandberg,Horng H. Chen,Lorenzo Malatino,Margaret M. Redfield,Richard J. Rodeheffer,John C. Burnett,Alessandro Cataliotti	78
6	Pro–B-Type Natriuretic Peptide1–108 Circulates in the General Community 2011 ·Journal of the American College of Cardiology ·Fima Macheret,Guido Boerrigter,Paul M. McKie,Lisa C. Costello‐Boerrigter,Brian D. Lahr,Denise M. Heublein,Sharon M. Sandberg,Yasuhiro Ikeda,Alessandro Cataliotti,(unknown),Richard J. Rodeheffer,John C. Burnett	61
7	Effect of cardiac resynchronization therapy on broad neurohormone biomarkers in heart failure 2011 ·Journal of Interventional Cardiac Electrophysiology ·(unknown),John C. Burnett,Horng H. Chen,Sharon M. Sandberg,(unknown),Zhang Yan-hua,Peng‐Sheng Chen,Yong‐Mei Cha	11
8	A novel chimeric natriuretic peptide reduces cardiomyocyte hypertrophy through the NHE-1–calcineurin pathway 2010 ·Cardiovascular Research ·Ana Kilić,Venkatesh Rajapurohitam,Sharon M. Sandberg,Asad Zeidan,James C. Hunter,(unknown),(unknown),John C. Burnett,Morris Karmazyn	24
9	Circulating Pronatriuretic Peptide Convertase Corin Is Present in Normal and Heart Failure Patients and Processes proBNP1-108 in Human Blood 2010 ·Journal of Cardiac Failure ·Tomoko Ichiki,Brenda K. Huntley,Denise M. Heublein,Sharon M. Sandberg,Paul M. McKie,Michihisa Jougasaki,John C. Burnett	1
10	Renal Mechanisms of Action of a Novel Designer Natriuretic Peptide, CU-NP 2008 ·Journal of Cardiac Failure ·Candace Y.W. Lee,Horng H. Chen,Sharon M. Sandberg,Gail J. Harty,John C. Burnett	2
11	Distinct roles for renal particulate and soluble guanylyl cyclases in preserving renal function in experimental acute heart failure 2007 ·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·Fernando L. Martín,Thanom Supaporn,Horng H. Chen,Sharon M. Sandberg,Yuzuru Matsuda,Michihisa Jougasaki,John C. Burnett	8
12	BNP‐induced activation of cGMP in human cardiac fibroblasts: Interactions with fibronectin and natriuretic peptide receptors 2006 ·Journal of Cellular Physiology ·Brenda K. Huntley,Sharon M. Sandberg,Josh A. Noser,Alessandro Cataliotti,Margaret M. Redfield,Yuzuru Matsuda,John C. Burnett	51
13	The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure 2002 ·Journal of Cardiac Failure ·(unknown),Tracy L. Stevens,Sharon M. Sandberg,Denise M. Heublein,Susan M. Nelson,Michihisa Jougasaki,Margaret M. Redfield,John C. Burnett	111
14	Attenuated natriuretic response to adrenomedullin in experimental heart failure 2001 ·Journal of Cardiac Failure ·Michihisa Jougasaki,D. M. Heublein,Sharon M. Sandberg,John Burnett	7
15	Angiotensin II in the Evolution of Experimental Heart Failure 1996 ·Hypertension ·Andreas Luchner,Tracy L. Stevens,Daniel D. Borgeson,Margaret M. Redfield,(unknown),Sharon M. Sandberg,Denise M. Heublein,John C. Burnett	58
16	776-4 Intact cNOS-NO-cGMP Pathway in the Failing Human Heart 1995 ·Journal of the American College of Cardiology ·Chiming Wei,John A. Lust,Zvonimir S. Katušić,Michihisa Jougasaki,Denise M. Heublein,Sharon M. Sandberg,Debra A. Lewis,Virginia M. Miller,Christopher G.A. McGregor,John C. Burnett	1
17	Immunohistochemical localization of adrenomedullin in canine heart and aorta 1995 ·Peptides ·Michihisa Jougasaki,Chi-Ming Wei,Denise M. Heublein,Sharon M. Sandberg,John C. Burnett	48
18	Presence of atrial natriuretic factor in ventricular tissue in tachycardia-induced cardiomyopathy 1994 ·The American Journal of Cardiology ·(unknown),Martha Grogan,Sharon M. Sandberg,Hugh C. Smith,B.J. Gersh,William D. Edwards,B.S. Edwards	5
19	The sodium retaining effects of cyclosporine 1992 ·Kidney International ·(unknown),Margaret A. Lloyd,Sharon M. Sandberg,Denise M. Heublein,Brooks S. Edwards	64
20	Circulating and Tissue Endothelin Immunoreactivity in Advanced Atherosclerosisbreakdown → 1991 ·New England Journal of Medicine ·Amir Lerman,Brooks S. Edwards,John W. Hallett,Denise M. Heublein,Sharon M. Sandberg,John C. Burnett	788

About Sharon M. Sandberg

Sharon M. Sandberg is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Cellular and Molecular Neuroscience, having authored 31 papers that have together received 1.8k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (18 papers), Renin-Angiotensin System Studies (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.2k citations), Physiology (648 citations) and Transplantation (32 citations). Sharon M. Sandberg has collaborated with scholars based in United States, Japan and Italy. Frequent co-authors include John C. Burnett, Denise M. Heublein, Brooks S. Edwards, John W. Hallett, Amir Lerman, Brenda K. Huntley, Margaret M. Redfield, Michihisa Jougasaki, Alessandro Cataliotti and Guido Boerrigter. Their work appears in journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact